Molbio Diagnostics Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,64,483 shares,. Its Average Traded Price (ATP) is ₹1246.51, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 11 @ ₹1254.50.
Molbio Diagnostics has an upper circuit limit of ₹1486.90 and a lower circuit limit of ₹991.30. The total value traded stands at ₹20.50 CR, and the delivery percentage for the day is 20.62%.
The stock is currently traded with a market lot size of 1. Molbio Diagnostics also offers a dividend yield of 0%.
Molbio Diagnostics Share Price Chart
Molbio Diagnostics Share Key Metrics
Volume
1.64 L
Market Cap
14279.39 CR
LTQ@LTP
11@1254.50
ATP
1246.51
Var Margin
20.45 %
Circuit Range
991.3-1486.9
Delivery %
20.62 %
Value
20.50 CR
ASM/GSM
No
Market Lot
1
Molbio Diagnostics Resistance and Support
Pivot 1257.5
Resistance
First Resistance
1286.5
Second Resistance
1333.9
Third Resistance
1362.9
Support
First Support
1210.1
Second Support
1181.1
Third Support
1133.7
Molbio Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-05 | Quarterly Results |
Molbio Diagnostics News
Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Kotak Mahindra Mutual Fund acquired 5,70,000 equity shares (0.49% stake) of Molbio Diagnostics via open market on October 8, 2026. This increases its total holding in the company from 4.98% to 5.48%.
Oct 16 2026 10:13:23
Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Kotak Mahindra Mutual Fund acquired 5.7 lakh shares of Molbio Diagnostics in the open market on 08 Oct 2026. This acquisition increases the fund's total stake from 4.98% to 5.48%, crossing the 5% regulatory reporting threshold.
Oct 13 2026 10:22:21
Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
India Business Excellence Fund III sold 30 lakh shares in Molbio Diagnostics via open market on September 23, 2026. This represents a 2.60% stake sale, reducing the fund's total shareholding in the company from 11.52% to 8.92%.
Oct 01 2026 15:40:31
Molbio Diagnostics Ltd - 544866 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
India Business Excellence Fund III disposed of 23.77 lakh shares (2.06% stake) in Molbio Diagnostics via open market on September 30, 2026. Following the sale, the fund's stake in the company decreased from 8.92% to 6.85%.
Oct 01 2026 10:20:57
Molbio Diagnostics Management
| Name | Position |
|---|---|
| Sriram Natarajan | Executive Director & Chief Executive Officer |
| Sangeetha Sriram | Executive Director - Operations |
Molbio Diagnostics Similar Stocks
Natco Pharma Ltd.
788.20
-3.65 (0.46%)
Alembic Pharmaceuticals Ltd.
767.55
7.45 (0.98%)
Jubilant Pharmova Ltd.
933.30
-5.00 (0.53%)
Dr. Agarwal's Health Care Ltd.
472.70
-1.20 (0.25%)
Poly Medicure Ltd.
1449.90
5.90 (0.41%)
Vijaya Diagnostic Centre Ltd.
1388.50
-0.90 (0.06%)
Marksans Pharma Ltd.
292.25
5.35 (1.86%)
Concord Biotech Ltd.
1272.00
42.70 (3.47%)
Alivus Life Sciences Ltd.
1253.80
3.20 (0.26%)
CORONA Remedies Ltd.
2055.00
3.90 (0.19%)
Molbio Diagnostics FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in MOLBIO
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC